Navigation Links
Cold-EEZE® Cold Remedy Awarded Coveted Parent Tested Parent Approved (PTPA) Seal of Approval
Date:11/17/2011

DOYLESTOWN, Pa., Nov. 17, 2011 /PRNewswire/ -- ProPhase Labs (NASDAQ: PRPH), makers of Cold-EEZE Cold Remedy, a leader in over-the-counter (OTC) homeopathic cold remedies, is excited to announce that Cold-EEZE has been awarded the Parent Tested Parent Approved (PTPA) Winner's Seal of Approval.  PTPA Media has North America's largest volunteer parent testing community, with over 40,000 parents. The seal of approval was awarded based on quality, effectiveness and value.

(Photo:  http://photos.prnewswire.com/prnh/20111117/NY09104 )

Cold-EEZE is the #1 pharmacist-recommended zinc cold remedy. Its proprietary zinc gluconate formula is clinically proven to safely and effectively reduce the duration and the severity of the symptoms of a common cold by nearly half (42%).

"This Seal of Approval reflects the high standards that we set for Cold-EEZE, and we are honored to receive this award," says Ted Karkus, Chairman and Chief Executive Officer of ProPhase Labs. "This recognition highlights the benefits and value that Cold-EEZE offers to families during the cough and cold season."

Cold-EEZE was among many entries from across North America competing to earn the PTPA™ Seal. Independent parent volunteers evaluate these products in their own homes. Therefore, PTPA winners are chosen based on merit and consumer experience – not on commercial considerations. As a result, the PTPA Media™ Seal has quickly gained recognition as an international leader in certifying consumer products for quality, effectiveness and value. PTPA's CEO and founder, Sharon Vinderine, has appeared on over 40 morning shows as a reliable source for the latest and greatest in family products. The media and parents alike trust the collective opinion that PTPA Media represents.

"At PTPA Media, we are proud to play a role in certifying innovative products that families can trust," says Vinderine. "When consumers search for our Seal of Approval on product packaging and web sites, they are essentially searching for validation from their peers.  Their peers will have objectively tested and approved these products based on their performance in a real life environment. That type of resource for families is priceless."

Cold-EEZE Cold Remedy has recently introduced a new convenient and great tasting Oral Spray version. Just two sprays of the Oral Spray deliver the same amount of cold remedy (active ingredient zinc gluconate) as one Cold-EEZE lozenge. Cold-EEZE is available at over 40,000 fine retail locations including all major food stores, drug chains and mass retailers.  To find a retailer or buy online please visit www.coldeeze.com.

About ProPhase Labs

ProPhase Labs is a diversified natural health medical science company. It is a leading marketer of the Cold-EEZE® cold remedy brand as well as other cold relief products.  Cold-EEZE® zinc gluconate lozenges are clinically proven to shorten the duration of the common cold by nearly half.  Cold-EEZE® customers include leading national retailers, food, chain drug and mass merchandise stores, wholesalers and distributors, as well as independent pharmacies.  ProPhase Labs has several wholly owned subsidiaries including a manufacturing unit, which consists of an FDA registered facility to manufacture Cold-EEZE® lozenges and fulfill other contract manufacturing opportunities.  ProPhase also owns 50% of Phusion Laboratories, LLC ("Phusion").  Phusion licenses a revolutionary proprietary technology that has the potential to improve the delivery and/or efficacy of many active ingredients or compounds.  Phusion will formulate and test products to exploit market opportunities within ProPhase's robust over-the-counter distribution channels.   For more information visit us at www.ProPhaseLabs.com.

About PTPA Media Inc.

PTPA Media provides an objective framework for appraising and promoting new products designed to enrich family living. The company's mission is to marry innovative companies with discerning consumers, to improve consumer access to quality products and services for their families and homes.

PTPA Media Contact Information: 

Janine Streiter, Tel: (905)738-1447 x240 For more information visit www.ptpamedia.com.

Media Contact:
Ilisa Wirgin/Jenny Miranda
212-999-5585
iwirgin@5wpr.com
jmiranda@5wpr.com


'/>"/>
SOURCE ProPhase Labs
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Help Your Favorite Charity Win $1,000 from Cold-EEZE®!
2. Fresenius Medical Care, N.A. Has Selected VitalRemedyMDs VitalProteinRx(TM) As Its Bar of Choice for Protein Replacement in Dialysis Patients
3. Phytomedics Inc. Announces Publication of the Phase 2b Clinical Trial Results of an Extract of the Chinese Herbal Remedy Tripterygium wilfordii Hook F in Rheumatoid Arthritis
4. NxStage Awarded Multi-Year Contract to Supply Atlantic Dialysis Management Services with Vasc-Alert Access Surveillance Solution
5. Masimo Awarded the American Association of Respiratory Cares 2011 Zenith Award
6. Psychemedics Awarded ISO/IEC 17025 International Accreditation
7. Life Spine Awarded Seven New Patents, Launches Six New Product Lines & Realizes 25% Sales Growth
8. ArjoHuntleigh Awarded Vascular Compression Contract With HealthTrust Purchasing Group
9. ImaginAb, Inc. Awarded $2.3 Million from the National Cancer Institute
10. Bacterin Awarded Approved Vendor Status for American Medical Concepts Network of Hospitals in the Northwest U.S.
11. Darah Medical Awarded GSA Schedule, Launches Online Store
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2017)... Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), today ... June 30, 2017, and updated its financial outlook for ... For the fiscal third quarter, Hill-Rom reported earnings of ... share in the prior-year period. These results reflect after-tax ... share primarily related to the non-cash write-down of assets ...
(Date:7/27/2017)... Pa., July 27, 2017  West Pharmaceutical Services, Inc. ... results for the second-quarter 2017 and updated financial guidance ... Second-Quarter 2017 Highlights Reported net ... over the prior-year quarter. Net sales at constant currency ... reported-diluted EPS was $0.51, compared to $0.60 in the ...
(Date:7/26/2017)... , July 26, 2017 Sancilio Pharmaceuticals Company, ... our clinical trial evaluating Altemia TM , an oral ... and Sickle Cell Disease (SCD). The SCOT Trial, is ... efficacy and safety of Altemia TM in pediatric ... under US IND 125274. ...
Breaking Medicine Technology:
(Date:8/16/2017)... Lewisville, TX (PRWEB) , ... August 16, 2017 , ... ... in the United States, named Dr. Douglas J. Harrison, as the new Medical Director ... will be the new facility Medical Director of our Sienna Plantation location,” said Dr. ...
(Date:8/16/2017)... ... , ... “God Will Break Every Chain”: an inspirational story for those shackled by the chains ... author, Evangelist Joann Shivers, a writer and a woman of great faith and wisdom. ... early age. She was born and raised in Vero Beach, Florida and has dedicated ...
(Date:8/15/2017)... ... August 15, 2017 , ... The first study to ... multiple myeloma has been completed, with the team’s findings now published online ahead of ... , Director of the Blood and Marrow Transplant Program at Roswell Park Cancer Institute, ...
(Date:8/15/2017)... ... August 15, 2017 , ... Progressive Dental, a leading ... on the 2017 Fast 50 list of Fastest Growing Companies in Tampa Bay. The ... area who has shown three consecutive years of growth. For this year’s award, Progressive ...
(Date:8/15/2017)... ... August 15, 2017 , ... Dr. Timothy Davis ... periodontal disease . This information can be used to develop patient-specific treatment ... The two salivary diagnostic tests, named MyPerioPath® and MyPerioID® are offered by OralDNA® ...
Breaking Medicine News(10 mins):